Determinación e interpretación de la sensibilidad a cefiderocol
South Health · 2024
DOI: 10.21142/sh-01-2024-e008 ↗Kurz gefasst
Fachartikel in der Zeitschrift South Health, 2024. Verfasst von Joaquim Ruiz und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cefiderocol is a new antibacterial agent active against Gram-negative bacteria of clinical interest. Cefiderocol passively penetrates the bacteria through porins and actively through iron uptake systems. This peculiarity results in the need to perform slight modifications when performing minimal inhibitory concentration assays. Thus, it is needed a cation-free culture media, and a thin grown is unconsidered.
Zitieren
APA
Ruiz, J., Egoávil-Espejo, R., Ymaña, B., Oporto-Llerena, R., & Pons, M. J. (2024). Determinación e interpretación de la sensibilidad a cefiderocol. South Health. https://doi.org/10.21142/sh-01-2024-e008
Vancouver
Ruiz J, Egoávil-Espejo R, Ymaña B, Oporto-Llerena R, Pons MJ. Determinación e interpretación de la sensibilidad a cefiderocol. South Health. 2024. doi:10.21142/sh-01-2024-e008
BibTeX
@article{Ruiz2024,
author = {Ruiz, Joaquim and Egoávil-Espejo, Rocio and Ymaña, Barbara and Oporto-Llerena, Rosario and Pons, Maria J.},
title = {Determinación e interpretación de la sensibilidad a cefiderocol},
journal = {South Health},
year = {2024},
doi = {10.21142/sh-01-2024-e008}
}
EUVIMED